Clinical trials
Heart failure clinical trials
A condition where the heart can’t pump blood as well as it should. We’re tracking 949 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07632586Recruiting
First-in-Human Heart Pump Implant Study
This trial tests a new tiny heart pump called the Icoms Flowmaker for patients with severe heart failure who cannot have a standard heart pump. The device may help your heart pump blood better and improve your ability to do daily activities.
PragueAges 18–80 - NCT07636759Recruiting
AI Heart Rhythm Test for Heart Pump Weakness
This study tests whether an artificial intelligence system can detect a weakened heart pump using an ECG (heart rhythm test). If successful, it could help doctors diagnose heart problems faster and more easily.
Suwon, Gyeonggi-doAges 19 years+ - NCT07636343Recruiting
Eccentric Training for Heart Failure Recovery
This trial tests a special type of strength training (eccentric exercise, where muscles lengthen under load) for people with heart failure who have reduced pumping ability. The goal is to improve your exercise capacity and heart function safely.
EdegemAges Any age - NCT04976348Recruiting
Heart monitoring registry for teens and adults with heart symptoms
This study registers people who are referred to cardiology or genetics for heart-failure–type symptoms or heart/cardiogenetic screening. It helps doctors understand how monitoring platforms may support diagnosis and follow-up.
Maastricht, LimburgAges 16 years+ - NCT07626879Recruiting
Ring Blood Pressure Device Compared to Standard 24-Hour Monitoring
This study tests whether a new ring-shaped blood pressure device works as well as the standard 24-hour ambulatory blood pressure monitor in people with heart failure. If the ring device is accurate, it could offer a simpler, more convenient way to track blood pressure at home.
DaeguAges 19 years+ - NCT06652750Recruiting
5G cloud-based check-up for heart device patients
This study tests whether a 5G-based remote check-up (over the cloud) is safe and effective for people with certain implanted heart devices, like pacemakers. You'll skip your first clinic visit and instead use a video call or remote check to see how your device is doing.
Guangzhou, GuangdongAges 18 years+ - NCT02856620Recruiting
Study heart function and frailty in people with aortic valve narrowing
This study looks at how heart mechanics, blood markers, and frailty relate to symptoms and heart measurements in people with aortic stenosis (a stiff, narrowed heart valve). It may help doctors better understand who is at higher risk and how disease changes over time.
Montreal, QuebecAges 18 years+ - NCT06699446Recruiting
Seamless care from before to after heart surgery
This study is for people who are getting ready for heart surgery and want to follow a program that helps them prepare and recover. It tests a seamless approach from before surgery through rehabilitation, focusing on exercise and support.
Hanover, Lower SaxonyAges 18 years+ - NCT05760924Recruiting
Testing a new heart pacing method for CRT nonresponders
This trial tests whether a different pacing approach called left bundle branch pacing can improve outcomes and heart structure changes in people who did not improve with standard biventricular CRT. It may help some patients with ongoing heart failure symptoms and weak heart pumping.
TomskAges 18–80 - NCT07604467Recruiting
Understanding Stem Cells in Takotsubo Heart Syndrome
This study examines how certain stem cells (CD34+ cells) may contribute to takotsubo syndrome, a temporary heart condition often triggered by stress. By understanding this connection, researchers hope to improve treatment and recovery for patients with this condition.
Ljubljana, LjubljanaAges 18 years+ - NCT07611084Recruiting
Atrial Fibrillation Study in Older Adults in Rural China
This study follows older adults in rural China who have atrial fibrillation (an irregular heart rhythm) to better understand the condition and screen for heart failure. Researchers want to learn more about how these conditions affect people in rural communities.
Taizhou, JiangsuAges 65–80 - NCT05971225Recruiting
Testing remote heart monitoring to improve heart outcomes
This study checks whether starting remote wireless heart monitoring for people with heart failure helps improve important heart outcomes. It may help your care team catch warning signs earlier by receiving your heart data from home.
Suwon, Kyonggi DoAges 20 years+ - NCT06304857RecruitingPhase 3
Protecting the heart with dapagliflozin during breast cancer treatment
This trial tests if the diabetes drug dapagliflozin can protect the heart in people with breast cancer receiving a type of chemotherapy called anthracyclines. You may be able to join if you are between 18 and 80, have stage I-III breast cancer, and are about to start anthracycline treatment within the next 60 days.
Wroclaw, Lower Silesian VoivodeshipAges 18–80 - NCT07601867Recruiting
Dapagliflozin to improve heart function after bypass surgery
This trial tests whether a diabetes medication called dapagliflozin can help improve how well the right side of your heart works after off-pump coronary artery bypass grafting surgery (a way to reroute blood around blocked heart arteries). The goal is to see if this drug reduces strain on your heart during recovery.
Pyatigorsk, Stavropol KrayAges 18 years+ - NCT07601087RecruitingPhase 1
Safety Study of HRS-7156 in Healthy Adults
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
Shanghai, Shanghai MunicipalityAges 18–55 - NCT06180603Recruiting
Draining lung fluid safely in the ER
This trial tests a better way to drain fluid from around the lung while you are in the emergency department. It can help you breathe easier and find out what is causing the fluid buildup.
Aarhus, Central JutlandAges 18 years+ - NCT07589452Recruiting
Pacemaker heart rate settings and blood pressure in older adults
This study tests whether a specific pacemaker heart-rate setting helps control blood pressure and improve heart function in adults over 65 with slow heartbeats and high blood pressure. You would receive a dual-chamber pacemaker (a standard treatment) and be monitored to see how the rate setting affects your health.
Taiyuan, ShanxiAges 65 years+ - NCT05428631Recruiting
Monitoring device tested in severe kidney and heart failure
This study checks how safe a small heart-pressure monitoring device is for people with advanced heart failure and severe kidney problems. It looks at whether doctors can continuously track heart filling/pressure to help manage symptoms and reduce risks.
Nîmes, GardAges 18–85 - NCT07569640RecruitingPhase 3
Heart failure combination pill study
This study tests a single pill that combines several heart failure medicines to see if it helps people with a weakened heart pump feel better and stay out of the hospital. It is being done in Sri Lanka and may offer a simpler way to take multiple medications.
Kandy, Central ProvinceAges 18 years+ - NCT07551167RecruitingPhase 1
Safety Study of HRS-5765 in Healthy Adults
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
Beijing, Beijing MunicipalityAges 18–65 - NCT07541768Recruiting
Training Residents to Use Ultrasound for Fluid Assessment
This study teaches medical residents how to use a bedside ultrasound technique called VExUS to check if patients have too much fluid in their body. You'll learn a specific skill that could help you assess patients faster and more accurately.
BernAges Any age - NCT07534462Recruiting
Heart pump and ultrasound heart function study
This study uses ultrasound (echocardiography) to see how the Impella 5.5 heart pump affects your heart's pumping ability, especially the right side. It might help doctors better understand and care for people who need this pump.
Rochester, New YorkAges 18 years+ - NCT07527715Recruiting
Heart MRI Study for Dilated Heart Muscle Disease
This research uses cardiac MRI scans and patient data to better predict outcomes in people with dilated cardiomyopathy—a condition where the heart's main pumping chamber becomes enlarged and weakened. Participating could help doctors improve how they care for similar patients in the future.
Jinan, ShandongAges 18 years+ - NCT07516288RecruitingPhase 1
Second CAR-DC Cell Infusion for Advanced Heart Failure
This trial tests a second dose of specialized immune cells (called CAR-DC) in patients with severe dilated cardiomyopathy (a weakened heart muscle) who received one dose before but saw their heart function decline back to baseline. The goal is to see if a second dose is safe and can improve heart function when the first treatment's benefits wore off.
Hangzhou, Zhejiang / 浙江Ages 18–75
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for heart failure?
- Yes. Clin2 currently lists 949 recruiting heart failure studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a heart failure trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a heart failure trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.